385 related articles for article (PubMed ID: 27258602)
21. Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP).
Lepley TJ; Wu Z; Root Z; Mountain D; Otto BA; Kelly K; Zhao K
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1578-1580. PubMed ID: 35765860
[No Abstract] [Full Text] [Related]
22. Efficacy and safety of erdosteine in the treatment of chronic rhinosinusitis with nasal polyposis - a pilot study.
Hoza J; Salzman R; Starek I; Schalek P; Kellnerova R
Rhinology; 2013 Dec; 51(4):323-7. PubMed ID: 24260764
[TBL] [Abstract][Full Text] [Related]
23. Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
Peters AT; Soler ZM; Kern RC; Heffler E; Maspero JF; Crampette L; Fujieda S; Lane AP; Zhang H; Nash S; Khan AH; Siddiqui S; Jacob-Nara JA; Rowe P; Deniz Y
Clin Exp Allergy; 2022 Sep; 52(9):1105-1109. PubMed ID: 35775319
[No Abstract] [Full Text] [Related]
24. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps.
van der Lans RJL; Fokkens WJ; Adriaensen GFJPM; Hoven DR; Drubbel JJ; Reitsma S
Allergy; 2022 Feb; 77(2):670-674. PubMed ID: 34626497
[No Abstract] [Full Text] [Related]
25. Mepolizumab for chronic rhinosinusitis with nasal polyps.
Brusselle GG; Gevaert P
Lancet Respir Med; 2021 Oct; 9(10):1081-1082. PubMed ID: 33872589
[No Abstract] [Full Text] [Related]
26. Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis.
Mostafa BE; Fadel M; Mohammed MA; Hamdi TAH; Askoura AM
Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):121-128. PubMed ID: 31552526
[TBL] [Abstract][Full Text] [Related]
27. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Budesonide Nasal Spray on Neutrophilic Chronic Rhinosinusitis with Nasal Polyps: A Combined Clinical and Experimental Study.
Lin L; Lan J; Dai F; Wei J; Chen Z; Sun G
Int Arch Allergy Immunol; 2020; 181(7):551-562. PubMed ID: 32369807
[TBL] [Abstract][Full Text] [Related]
29. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status.
Fujieda S; Matsune S; Takeno S; Ohta N; Asako M; Bachert C; Inoue T; Takahashi Y; Fujita H; Deniz Y; Rowe P; Ortiz B; Li Y; Mannent LP
Allergy; 2022 Jan; 77(1):186-196. PubMed ID: 33993501
[TBL] [Abstract][Full Text] [Related]
30. Oral Therapeutics for Rhinosinusitis with Nasal Polyposis.
Thomas AJ; Alt JA
Adv Otorhinolaryngol; 2016; 79():138-47. PubMed ID: 27466856
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory innate lymphoid cells predict response speed to dupilumab in chronic rhinosinusitis with nasal polyps.
Golebski K; van der Lans RJL; van Egmond D; de Groot E; Spits H; der Zee AM; van Drunen CM; Fokkens WJ; Reitsma S
Allergy; 2023 Dec; 78(12):3265-3268. PubMed ID: 37705461
[No Abstract] [Full Text] [Related]
32. Do preoperative corticosteroids benefit patients with chronic rhinosinusitis with nasal polyposis?
Carlton DA; Chiu AG
Laryngoscope; 2019 Apr; 129(4):773-774. PubMed ID: 30408190
[No Abstract] [Full Text] [Related]
33. Nasal Polyposis and Its Association with Cardiac Functions.
Dhiman S; Dhiman A; Azad RK; Negi PC; Lal B; Thakur JS
Med Princ Pract; 2021; 30(6):522-526. PubMed ID: 34348323
[TBL] [Abstract][Full Text] [Related]
34. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
35. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis.
Aschenbrenner DS
Am J Nurs; 2019 Oct; 119(10):21-22. PubMed ID: 31567245
[No Abstract] [Full Text] [Related]
36. Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment.
Venkatesan N; Lavigne P; Lavigne F; Hamid Q
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):213-8. PubMed ID: 26405064
[TBL] [Abstract][Full Text] [Related]
37. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
Fokkens W; Van Der Lans R; Reitsma S
Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
[No Abstract] [Full Text] [Related]
38. Efficacy of Short-Term Systemic Corticosteroid Therapy in Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Randomized Controlled Trials and Systematic Review.
Zhang Y; Wang C; Huang Y; Lou H; Zhang L
Am J Rhinol Allergy; 2019 Sep; 33(5):567-576. PubMed ID: 31132854
[No Abstract] [Full Text] [Related]
39. Monoclonal Antibodies for the Treatment of Nasal Polyps.
Willson TJ; Naclerio RM; Lee SE
Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Dexamethasone Versus Fluticasone Nasal Sprays in Postoperative Patients With Chronic Rhinosinusitis With Nasal Polyps.
Seiberling KA; Kidd SC; Kim GH; Church CA
Am J Rhinol Allergy; 2019 Sep; 33(5):478-482. PubMed ID: 30987428
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
